Across TCGA pan-cancer cohorts, MORF4L1P7 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MORF4L1P7 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MORF4L1P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MORF4L1P7 expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

BLCA, LIHC, and LGG are the cancer types where MORF4L1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.308	0.631	.001	60	view →
LIHC	DFS	Tertile	III,IV	1.000	0.223	.039	12	view →
LGG	DFS	Tertile	All	0.533	0.736	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MORF4L1P7 tumor-vs-normal RNA expression · all MORF4L1P7 data types